Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Oxybutynin Chloride Extended-Release Tablets USP Rx Only These highlights do not include all the information needed to use Oxybutynin chloride extended-release tablets safely and effectively. See full prescribing information for Oxybutynin chloride extended-release tablets. Oxybutynin chloride extended-release tablets for oral use Initial U.S. Approval: 1975
Medication labelWhy this: Advisory · dailymed-prescription
Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida).
- generic_name
- oxybutynin chloride
- product_names
- Oxybutynin Chloride
- ndc
- 42291-633, 62175-270, 42291-633-01, 42291-633-50, 42291-634, 62175-271, 42291-634-01, 42291-634-50, 42291-635, 62175-272, 42291-635-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en